Editorial Gastroenterology Oncology Trauma
In-hospital mortality after vitamin D supplementation in adults with type 2 diabetes: A pilot feasibility study

In-hospital mortality after vitamin D supplementation in adults with type 2 diabetes: A pilot feasibility study

Authors

Sarah Andersen

Sarah Andersen

Karolinska University Hospital, Norfolk Island

Arjun Nakamura

Arjun Nakamura

Cleveland Clinic Abu Dhabi, Somalia

Yusuf Andersen

Yusuf Andersen

American University of Beirut Medical Center, Nauru

Rania Nakamura

Rania Nakamura

Charité Berlin, Bouvet Island

Mei Volkov

Mei Volkov

Hamad Medical Corporation, United States

Corresponding
Mariam Mueller

Mariam Mueller

Aga Khan University Hospital, Peru

Published

July 3, 2024

Paper ID

PAP-000022

Status

Published

DOI

10.65712/tmj.test000280

In-hospital mortality after vitamin D supplementation in adults with type 2 diabetes: A pilot feasibility study

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: in-hospital mortality remains a leading cause of avoidable harm among adults with type 2 diabetes. Methods: Missing data were handled with multiple imputation. Results: in-hospital mortality occurred in 20% of the intervention group versus 19% of controls. The adjusted odds ratio was 0.39 (95% CI 0.27 to 0.63). Conclusion: Future work should test vitamin D supplementation in a pragmatic multicentre trial.

References

1. Silva O, Silva G, et al. Early mobilisation and length of stay. N Engl J Med. 2021;99(5):48-1450.

2. Kim M, Ibrahim C, et al. Tranexamic acid and 30-day readmission. Lancet. 2014;37(4):878-1379.

3. Moreau A, Tanaka A, et al. Tranexamic acid and chronic pain scores. Diabetes Care. 2023;180(11):53-1080.

4. Osei X, Ahmed M, et al. Low-dose aspirin and length of stay. JAMA. 2012;266(9):599-1496.

5. Ahmed J, Patel F, et al. SGLT2 inhibitors and ventilator-free days. JAMA. 2025;244(5):603-1170.

6. Mensah U, Nakamura W, et al. Pharmacist-led medication review and health-related quality of life. BMJ. 2009;326(7):802-1549.

7. Volkov T, Ahmed T, et al. SGLT2 inhibitors and ventilator-free days. Ann Intern Med. 2020;95(1):861-1178.

Introduction

Guidelines make only a weak recommendation on vitamin D supplementation. Practice around vitamin D supplementation varies widely between centres. in-hospital mortality remains a leading cause of avoidable harm among adults with type 2 diabetes.

Practice around vitamin D supplementation varies widely between centres. Guidelines make only a weak recommendation on vitamin D supplementation. The cost of in-hospital mortality to health systems is substantial.

Materials and Methods

Analyses were adjusted for age, sex and baseline severity.

Analyses were adjusted for age, sex and baseline severity.

We conducted a pilot feasibility study across 11 centres between 2015 and 2025. Analyses were adjusted for age, sex and baseline severity.

Results

2766 participants were included (median age 76 years). Serious adverse events were rare and similar between groups.

in-hospital mortality occurred in 11% of the intervention group versus 18% of controls. Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.

3643 participants were included (median age 81 years). 2138 participants were included (median age 42 years). Effects were consistent across prespecified subgroups.

GroupnEvents
Male8517
Age < 65769112
Female17830
Age < 6529290
Male51658
Control212108
Intervention89626
TABLE 1: Primary outcome by group
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Kaplan–Meier curve for in-hospital mortality
Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.

3904 participants were included (median age 49 years). 4588 participants were included (median age 35 years). 836 participants were included (median age 35 years). The adjusted odds ratio was 0.66 (95% CI 0.25 to 0.71).

The adjusted odds ratio was 0.79 (95% CI 0.49 to 0.92). 270 participants were included (median age 77 years).

Discussion

Implementation will depend on staffing, cost and local protocols. Future work should test vitamin D supplementation in a pragmatic multicentre trial.

Future work should test vitamin D supplementation in a pragmatic multicentre trial. These findings suggest that vitamin D supplementation is associated with better in-hospital mortality in adults with type 2 diabetes.

Conclusions

Vitamin D supplementation may be offered for adults with type 2 diabetes to improve in-hospital mortality.

Appendices

Supplementary tables are available on request.